This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Pharmacia Ab, Pfizer Health Ab. Active years: 2003-2006.
Company Filing History:
Years Active: 2003-2006
Title: Lene Orup Jacobsen: Innovator in Pharmaceutical Formulations
Introduction
Lene Orup Jacobsen is a notable inventor based in Gentofte, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of overactive bladder. With a total of 3 patents to her name, her work focuses on innovative drug delivery systems.
Latest Patents
One of her latest patents is titled "Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder." This invention involves a set of formulations that include tolterodine and its derivatives, designed for various modes of administration, including transdermal and oral routes. The goal is to effectively manage symptoms associated with overactive bladder. Another significant patent is "Therapeutic formulation for administering tolterodine with controlled release." This invention aims to provide a controlled release formulation that maintains a consistent serum level of the active ingredient for at least 24 hours, enhancing the treatment of unstable or overactive urinary bladder.
Career Highlights
Lene has worked with prominent companies in the pharmaceutical industry, including Pharmacia AB and Pfizer Health AB. Her experience in these organizations has contributed to her expertise in drug formulation and delivery systems.
Collaborations
Throughout her career, Lene has collaborated with talented professionals, including Ulla Hoeck and Helle Kristensen. These partnerships have likely enriched her research and development efforts.
Conclusion
Lene Orup Jacobsen's innovative work in pharmaceutical formulations demonstrates her commitment to improving treatments for overactive bladder. Her patents reflect a deep understanding of drug delivery mechanisms and patient needs.